Abstract:Transmembrane signaling is a critical process by which changes in the extracellular environment are relayed to intracellular systems that induce changes in homeostasis. One family of intracellular systems are the guanine nucleotide exchange factors (GEFs), which catalyze the exchange of GTP for GDP bound to inactive guanine nucleotide binding proteins (G proteins). The resulting active G proteins then interact with downstream targets that control cell proliferation, growth, shape, migration, adhesion, and transcription. Dysregulation of any of these processes is a hallmark of cancer. The Dbl family of GEFs activates Rho family G proteins, which, in turn, alter the actin cytoskeleton and promote gene transcription. Although they have a common catalytic mechanism exercised by their highly conserved Dbl homology (DH) domains, Dbl GEFs are regulated in diverse ways, often involving the release of autoinhibition imposed by accessory domains. Among these domains, the pleckstrin homology (PH) domain is the most commonly observed and found immediately C-terminal to the DH domain. The domain has been associated with both positive and negative regulation. Recently, some atomic structures of Dbl GEFs have been determined that reemphasize the complex and central role that the PH domain can play in orchestrating regulation of the DH domain. Here, we discuss these newer structures, put them into context by cataloging the various ways that PH domains are known to contribute to signaling across the Dbl family, and discuss how the PH domain might be exploited to achieve selective inhibition of Dbl family RhoGEFs by small-molecule therapeutics. SIGNIFICANCE STATEMENT Dysregulation via overexpression or mutation of Dbl family Rho guanine nucleotide exchange factors (GEFs) contributes to cancer and neurodegeneration. Targeting the Dbl homology catalytic domain by small-molecule therapeutics has been challenging due to its high conservation and the lack of a discrete binding pocket. By evaluating some new autoinhibitory mechanisms in the Dbl family, we demonstrate the great diversity of roles played by the regulatory domains, in particular the PH domain, and how this holds tremendous potential for the development of selective therapeutics that modulate GEF activity.

Serine Phosphorylation Negatively Regulates RhoA in Vivo

cGMP-Dependent Protein Kinase Phosphorylates and Inactivates RhoA

Differential Phosphorylation Regulates The Shear Stress-Induced Polar Activity Of Rho-Specific Guanine Nucleotide Dissociation Inhibitor Alpha

Molecular mechanism of regulation of RhoA GTPase by phosphorylation of RhoGDI

Multiple Phosphorylation Sites in RGS16 Differentially Modulate Its GAP Activity

Rho Is Required for Gαq and α1-Adrenergic Receptor Signaling in Cardiomyocytes

Phosphorylation Weakens but Does Not Inhibit Membrane Binding and Clustering of K-Ras4B.

Serine 176 Phosphorylation Attenuates Kinesin'S Stall Force and Biases Bidirectional Transport

Optical regulation of endogenous RhoA reveals selection of cellular responses by signal amplitude

Protein kinase A phosphorylation of RhoA mediates the morphological and functional effects of cyclic AMP in cytotoxic lymphocytes.

The Small GTP-Binding Protein RhoA Regulates a Delayed Rectifier Potassium Channel

Signaling Through Rho GTPase Pathway As Viable Drug Target.

Arp2/3-Branched Actin Maintains an Active Pool of GTP-RhoA and Controls RhoA Abundance.

Mechanisms of Guanine Nucleotide Exchange and Rac-Mediated Signaling Revealed by A Dominant Negative Trio Mutant

RhoA regulation in space and time

Arp2/3-Branched Actin Maintains an Active Pool of GTP-RhoA and Controls RhoA Abundance

Type II cGMP‑dependent protein kinase inhibits RhoA activation in gastric cancer cells.

Direct Interaction of P21-Activated Kinase 4 with PDZ-RhoGEF, a G Protein-linked Rho Guanine Exchange Factor*

Mammalian Rho GTPases: new insights into their functions from in vivo studies

RhoG protein regulates glycoprotein VI-Fc receptor γ-chain complex-mediated platelet activation and thrombus formation.

New Mechanisms Underlying Oncogenesis in Dbl Family Rho Guanine Nucleotide Exchange Factors